GlassScriptPhysician profile
Wen Cheng
NPI 1073597043
$2,890.08
in general payments reported to CMS, 2019-2025
9 companies · $509 in 2025
The $509 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $206 · 2021: $88.91 · 2022: $339 · 2023: $253 · 2024: $546 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,308.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,420.18 | 2019-2025 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $933.61 | 2019-2022 | |
| Abiomed | $150.00 | 2022 | |
| Artivion, INC. | $131.77 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $118.81 | 2025 | Airsupra |
| Atricure, INC. | $72.13 | 2019-2021 | |
| Medtronic, INC. | $23.47 | 2022 | |
| Boston Scientific Corporation | $22.61 | 2019 | |
| Medtronic Vascular, INC. | $17.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wen Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.